©The Author(s) 2025.
World J Clin Cases. Nov 16, 2025; 13(32): 110154
Published online Nov 16, 2025. doi: 10.12998/wjcc.v13.i32.110154
Published online Nov 16, 2025. doi: 10.12998/wjcc.v13.i32.110154
Table 2 Suggested approach for challenges in the management of tuberculosis with comorbid diabetes mellitus
| Challenge | Suggested approach | Ref. |
| Delayed TB diagnosis in DM patients | Systematic TB screening in DM clinics | WHO 2023 Framework[37,38] |
| Poor TB treatment outcomes in DM | Aggressive glycaemic control; close follow-up during TB therapy | Huangfu et al[27], 2019 |
| Drug-drug interactions affecting glycaemic control | Monitor blood glucose closely; adjust anti-diabetic medications | Restrepo[25], 2016 |
| Rifampicin-induced hyperglycaemia | Increased SMBG (self-monitoring of blood glucose) during intensive phase | Restrepo[25], 2016 |
| Lack of bi-directional screening at program level | Integrate DM screening in TB programs and TB screening in DM clinics | WHO 2023 Framework[37,38] |
| Poor patient adherence due to complex dual disease burden | Patient-centred care, education, counselling, and peer support | WHO 2023 Framework[37,38] |
| Lack of integrated clinical guidelines | Develop national guidelines on collaborative TB-DM management | WHO 2023 Framework[37,38] |
- Citation: Verma AK, Vats Y, Bajpai J, Kar SK, Pradhan A, Kant S. Pulmonary tuberculosis in diabetes: Exploring the intersection and impact on mental health. World J Clin Cases 2025; 13(32): 110154
- URL: https://www.wjgnet.com/2307-8960/full/v13/i32/110154.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i32.110154